Arrowstreet Capital, Limited Partnership Bausch Health Companies Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 4,770,793 shares of BHC stock, worth $29.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,770,793
Previous 3,260,348
46.33%
Holding current value
$29.4 Million
Previous $26.6 Million
44.71%
% of portfolio
0.03%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding BHC
# of Institutions
264Shares Held
250MCall Options Held
5.88MPut Options Held
9.78M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$214 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$170 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$163 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$95 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$80.1 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.23B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...